CADTH reimbursement reviews are comprehensive assessments of the clinical effectiveness and cost-effectiveness, as well patient clinician perspectives, a drug or class.
 The inform non-binding recommendations that help guide decisions Canada’s federal, provincial, territorial governments, with exception Quebec.
 This review assesses brexucabtagene autoleucel (Tecartus) cell sus...

After infections, malignancies, lymphomas especially, are the second most frequent cause of death in patients with inborn errors immunity. Factors predetermining appearance and aggressiveness include gene defects, defects immune surveillance regulation as well infections oncogenic viruses. Aggressive non-Hodgkin lymphomas, mostly diffuse large B-cell Bukit subtypes predominant deoxyribonucleic ...

Based on the life-time cost to the health care system, the Institute of Medicine has assigned the highest priority for a vaccine to control human cytomegalovirus (HCMV) disease in transplant patients and new born babies. In spite of numerous attempts successful licensure of a HCMV vaccine formulation remains elusive. Here we have developed a novel chimeric vaccine strategy based on a replicatio...